Results 1 to 10 of about 2,224,514 (245)

Carcinoid Syndrome: A Review. [PDF]

open access: yesCureus, 2020
Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra ...
Gade AK, Olariu E, Douthit NT.
europepmc   +6 more sources

European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease. [PDF]

open access: yesJ Neuroendocrinol, 2022
Carcinoid Heart Disease Clinic, Department of Cardiology, Royal Free Hospital & University College London, London, UK Department of Internal Medicine, Section of Endocrinology, ENETS Center of Excellence, Erasmus MC and Erasmus Cancer Institute ...
Grozinsky-Glasberg S   +13 more
europepmc   +2 more sources

Carcinoid syndrome: update on the pathophysiology and treatment

open access: yesClinics, 2018
Approximately 30-40% of patients with well-differentiated neuroendocrine tumors present with carcinoid syndrome, which is a paraneoplastic syndrome associated with the secretion of several humoral factors.
Anezka C. Rubin de Celis Ferrari   +2 more
doaj   +2 more sources

Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome. [PDF]

open access: yesJ Oncol, 2020
Carcinoid syndrome (CS) develops in patients with hormone-producing neuroendocrine neoplasms (NENs) when hormones reach a significant level in the systemic circulation. The classical symptoms of carcinoid syndrome are flushing, diarrhoea, abdominal pain,
Clement D, Ramage J, Srirajaskanthan R.
europepmc   +2 more sources

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome.

open access: yesJ Clin Endocrinol Metab, 2021
Context Peptide receptor radionuclide therapy (PRRT) with [Lutetium-177-DOTA0-Tyr3]octreotate (177Lu-DOTATATE) results in an increase of progression-free survival and quality of life in patients with progressive, well-differentiated neuroendocrine ...
Zandee WT   +6 more
europepmc   +2 more sources

Serotonin and the carcinoid syndrome [PDF]

open access: bronzeCanadian Anaesthetists’ Society Journal, 1959
A brief description of some of the main physiological actions of serotonin has been given. Their clinical implications, especially where they pertain to the field of anaesthesia, are presented in some detail. The malignant carcinoid syndrome is discussed and some of the problems which may confront the anaesthesiologist in dealing with patients ...
W. Philip G. Jones
openaire   +4 more sources

The role of serotonin inhibition within the treatment of carcinoid syndrome [PDF]

open access: yesEndocrine Oncology, 2023
Carcinoid syndrome is the most frequent hormonal complication associated with neuroendocrine neoplasms. It was first reported in 1954, and the classical symptoms are diarrhoea, flushing and abdominal pain.
Joel George   +3 more
doaj   +2 more sources

Endobronchial Carcinoid and Concurrent Carcinoid Syndrome in an Adolescent Female

open access: yesCase Reports in Pediatrics, 2016
Endobronchial carcinoid tumors are the most common intrabronchial tumors in children and adolescents. Common signs and symptoms include persistent cough and wheezing not responsive to bronchodilators, hemoptysis, and recurrent fever.
Jonathan D. Cogen   +2 more
doaj   +2 more sources

Duodenal carcinoid with carcinoid syndrome [PDF]

open access: yesBMJ Case Reports, 2014
Carcinoid tumours are uncommon well-differentiated neuroendocrine tumours. Primary duodenal carcinoids account for less than 2% of all gastrointestinal carcinoids. Duodenal carcinoids are seldom associated with carcinoid syndrome. We report a rare case of duodenal carcinoid presenting as a carcinoid syndrome in a middle-aged man with upper abdominal ...
Kamesh Konchada   +3 more
openaire   +4 more sources

Management of Diarrhea in Patients With Carcinoid Syndrome. [PDF]

open access: yesPancreas, 2019
Neuroendocrine tumors (NETs) arise from enterochromaffin cells found in neuroendocrine tissues, with most occurring in the gastrointestinal tract. The global incidence of NETs has increased in the past 15 years, likely due to better diagnostic methods ...
Naraev BG   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy